Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
11%(1 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_2
4
25%
Ph phase_4
7
44%
Ph phase_3
1
6%
Ph early_phase_1
1
6%
Ph phase_1
2
13%

Phase Distribution

3

Early Stage

4

Mid Stage

8

Late Stage

Phase Distribution15 total trials
Early Phase 1First-in-human
1(6.7%)
Phase 1Safety & dosage
2(13.3%)
Phase 2Efficacy & side effects
4(26.7%)
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
7(46.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(9)
Terminated(2)
Other(5)

Detailed Status

Completed9
unknown5
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.7%)
Phase 12 (13.3%)
Phase 24 (26.7%)
Phase 31 (6.7%)
Phase 47 (46.7%)

Trials by Status

terminated213%
unknown531%
completed956%

Recent Activity

0 active trials
Showing 5 of 16
completedphase_1

Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn

NCT06860399
terminatedphase_2

Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

NCT01002534
completedphase_4

Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)

NCT02450188
terminatedearly_phase_1

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

NCT02279992
unknownphase_4

Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis

NCT02344823
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06860399Phase 1

Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn

Completed
NCT01002534Phase 2

Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

Terminated
NCT02450188Phase 4

Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)

Completed
NCT02279992Early Phase 1

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

Terminated
NCT02344823Phase 4

Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis

Unknown
NCT01168817Phase 2

Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors

Completed
NCT02219646Phase 2

Diabetes & Vardenafil

Completed
NCT00853840Phase 4

Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc

Completed
NCT01260285Phase 1

The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

Completed
NCT01406535

Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease

Unknown
NCT01084187Phase 4

Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction

Completed
NCT01291199Phase 2

Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome

Completed
NCT00498680Phase 4

Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i

Unknown
NCT00718952Phase 3

The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension

Completed
NCT00725790Phase 4

A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury

Unknown
NCT00705588Phase 4

Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16